The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CHEMBL157655     1,3-dipropyl-7H-purine-2,6- dione

Synonyms: SureCN515771, AG-J-18230, SureCN4983107, ANW-66126, CHEBI:361347, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of CPX


High impact information on CPX


Chemical compound and disease context of CPX


Biological context of CPX


Anatomical context of CPX


Associations of CPX with other chemical compounds


Gene context of CPX


Analytical, diagnostic and therapeutic context of CPX


  1. Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium. Yao, Z., Gross, G.J. Circulation (1993) [Pubmed]
  2. ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line. Gerwins, P., Fredholm, B.B. J. Biol. Chem. (1992) [Pubmed]
  3. Adenosine A(1) receptor antagonist and mitochondrial ATP-sensitive potassium channel blocker attenuate the tolerance to focal cerebral ischemia in rats. Yoshida, M., Nakakimura, K., Cui, Y.J., Matsumoto, M., Sakabe, T. J. Cereb. Blood Flow Metab. (2004) [Pubmed]
  4. Hypoxic changes in rat locus coeruleus neurons in vitro. Nieber, K., Sevcik, J., Illes, P. J. Physiol. (Lond.) (1995) [Pubmed]
  5. 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator. Cohen, B.E., Lee, G., Jacobson, K.A., Kim, Y.C., Huang, Z., Sorscher, E.J., Pollard, H.B. Biochemistry (1997) [Pubmed]
  6. A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells. Eidelman, O., Guay-Broder, C., van Galen, P.J., Jacobson, K.A., Fox, C., Turner, R.J., Cabantchik, Z.I., Pollard, H.B. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  7. Dysregulation of adenosine A1 receptor-mediated cytokine expression in peripheral blood mononuclear cells from multiple sclerosis patients. Mayne, M., Shepel, P.N., Jiang, Y., Geiger, J.D., Power, C. Ann. Neurol. (1999) [Pubmed]
  8. Role of adenosine in insulin-stimulated release of leptin from isolated white adipocytes of Wistar rats. Cheng, J.T., Liu, I.M., Chi, T.C., Shinozuka, K., Lu, F.H., Wu, T.J., Chang, C.J. Diabetes (2000) [Pubmed]
  9. Direct activation of cystic fibrosis transmembrane conductance regulator channels by 8-cyclopentyl-1,3-dipropylxanthine (CPX) and 1,3-diallyl-8-cyclohexylxanthine (DAX). Arispe, N., Ma, J., Jacobson, K.A., Pollard, H.B. J. Biol. Chem. (1998) [Pubmed]
  10. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. Bullough, D.A., Magill, M.J., Firestein, G.S., Mullane, K.M. J. Immunol. (1995) [Pubmed]
  11. Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart. Flood, A.J., Willems, L., Headrick, J.P. Cardiovasc. Res. (2002) [Pubmed]
  12. Does nitric oxide allow endothelial cells to sense hypoxia and mediate hypoxic vasodilatation? In vivo and in vitro studies. Edmunds, N.J., Moncada, S., Marshall, J.M. J. Physiol. (Lond.) (2003) [Pubmed]
  13. Adenosine A1 receptors mediate mobilization of calcium in human bronchial smooth muscle cells. Ethier, M.F., Madison, J.M. Am. J. Respir. Cell Mol. Biol. (2006) [Pubmed]
  14. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation. Guay-Broder, C., Jacobson, K.A., Barnoy, S., Cabantchik, Z.I., Guggino, W.B., Zeitlin, P.L., Turner, R.J., Vergara, L., Eidelman, O., Pollard, H.B. Biochemistry (1995) [Pubmed]
  15. Intrinsic A(1) adenosine receptor activation during ischemia or reperfusion improves recovery in mouse hearts. Peart, J., Headrick, J.P. Am. J. Physiol. Heart Circ. Physiol. (2000) [Pubmed]
  16. Mediation of the vasoactive properties of diadenosine tetraphosphate via various purinoceptors. van der Giet, M., Jankowski, J., Schlüter, H., Zidek, W., Tepel, M. J. Hypertens. (1998) [Pubmed]
  17. Solubilization of stable adenosine A1 receptors from rat brain. Helmke, S.M., Cooper, D.M. Biochem. J. (1989) [Pubmed]
  18. Effects of exogenous ATP and related analogues on the proliferation rate of dissociated primary cultures of rat astrocytes. Ciccarelli, R., Di Iorio, P., Ballerini, P., Ambrosini, G., Giuliani, P., Tiboni, G.M., Caciagli, F. J. Neurosci. Res. (1994) [Pubmed]
  19. Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischaemia. Finegan, B.A., Lopaschuk, G.D., Gandhi, M., Clanachan, A.S. Br. J. Pharmacol. (1996) [Pubmed]
  20. Cerebral oxygenation during postasphyxial seizures in near-term fetal sheep. Gonzalez, H., Hunter, C.J., Bennet, L., Power, G.G., Gunn, A.J. J. Cereb. Blood Flow Metab. (2005) [Pubmed]
  21. ATP contributes to the generation of network-driven giant depolarizing potentials in the neonatal rat hippocampus. Safiulina, V.F., Kasyanov, A.M., Sokolova, E., Cherubini, E., Giniatullin, R. J. Physiol. (Lond.) (2005) [Pubmed]
  22. Adenosine mediates decreased cerebral metabolic rate and increased cerebral blood flow during acute moderate hypoxia in the near-term fetal sheep. Blood, A.B., Hunter, C.J., Power, G.G. J. Physiol. (Lond.) (2003) [Pubmed]
  23. Modulation of A1 adenosine receptor signaling by peroxynitrite. Giuntini, J., Giusti, L., Lucacchini, A., Mazzoni, M.R. Biochem. Pharmacol. (2004) [Pubmed]
  24. Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography. Johansson, B., Fredholm, B.B. Neuropharmacology (1995) [Pubmed]
  25. Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist. Nakamura, M., Nakakimura, K., Matsumoto, M., Sakabe, T. J. Cereb. Blood Flow Metab. (2002) [Pubmed]
  26. Pharmacological characterization of the adenylate cyclase-coupled adenosine receptor in isolated guinea pig atrial myocytes. Wilken, A., Tawfik-Schlieper, H., Klotz, K.N., Schwabe, U. Mol. Pharmacol. (1990) [Pubmed]
  27. In vivo effects of adenosine A1 receptor agonist and antagonist on neuronal and astrocytic intermediary metabolism studied with ex vivo 13C NMR spectroscopy. Håberg, A., Qu, H., Haraldseth, O., Unsgård, G., Sonnewald, U. J. Neurochem. (2000) [Pubmed]
  28. Adenosine A2a receptor-mediated modulation of striatal [3H]GABA and [3H]acetylcholine release. Kirk, I.P., Richardson, P.J. J. Neurochem. (1994) [Pubmed]
  29. Evidence for presynaptic adenosine A2a receptors associated with norepinephrine release and their desensitization in the rat nucleus tractus solitarius. Barraco, R.A., Clough-Helfman, C., Goodwin, B.P., Anderson, G.F. J. Neurochem. (1995) [Pubmed]
  30. Luminal adenosine stimulates chloride secretion through A1 receptor in mouse jejunum. Ghanem, E., Lövdahl, C., Daré, E., Ledent, C., Fredholm, B.B., Boeynaems, J.M., Van Driessche, W., Beauwens, R. Am. J. Physiol. Gastrointest. Liver Physiol. (2005) [Pubmed]
  31. In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling. Reid, E.A., Kristo, G., Yoshimura, Y., Ballard-Croft, C., Keith, B.J., Mentzer, R.M., Lasley, R.D. Am. J. Physiol. Heart Circ. Physiol. (2005) [Pubmed]
  32. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice. Zhao, T., Xi, L., Chelliah, J., Levasseur, J.E., Kukreja, R.C. Circulation (2000) [Pubmed]
  33. Adenosine receptor subtypes and vasodilatation in rat skeletal muscle during systemic hypoxia: a role for A1 receptors. Bryan, P.T., Marshall, J.M. J. Physiol. (Lond.) (1999) [Pubmed]
  34. A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis. McCarty, N.A., Standaert, T.A., Teresi, M., Tuthill, C., Launspach, J., Kelley, T.J., Milgram, L.J., Hilliard, K.A., Regelmann, W.E., Weatherly, M.R., Aitken, M.L., Konstan, M.W., Ahrens, R.C. Pediatr. Pulmonol. (2002) [Pubmed]
  35. A1 adenosine receptor antagonists as ligands for positron emission tomography (PET) and single-photon emission tomography (SPET). Holschbach, M.H., Fein, T., Krummeich, C., Lewis, R.G., Wutz, W., Schwabe, U., Unterlugauer, D., Olsson, R.A. J. Med. Chem. (1998) [Pubmed]
  36. Inhibitory effect of ischemic preconditioning on leukocyte participation in retinal ischemia-reperfusion injury. Nonaka, A., Kiryu, J., Tsujikawa, A., Yamashiro, K., Nishijima, K., Miyamoto, K., Nishiwaki, H., Honda, Y., Ogura, Y. Invest. Ophthalmol. Vis. Sci. (2001) [Pubmed]
  37. Inhibition of calcium channels by opioid- and adenosine-receptor agonists in neurons of the nucleus accumbens. Chieng, B., Bekkers, J.M. Br. J. Pharmacol. (2001) [Pubmed]
  38. Activation of A1 adenosine receptors decreases the release of serotonin in the rabbit hippocampus, but not in the caudate nucleus. Feuerstein, T.J., Bär, K.I., Lücking, C.H. Naunyn Schmiedebergs Arch. Pharmacol. (1988) [Pubmed]
  39. Comparison of an adenosine A1 receptor agonist and antagonist on the rat EEG. Fulga, I., Stone, T.W. Neurosci. Lett. (1998) [Pubmed]
WikiGenes - Universities